(AME) Ametek - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 51.766m USD | Total Return: 29.9% in 12m
Avg Turnover: 249M
EPS Trend: 91.2%
Qual. Beats: 1
Rev. Trend: 97.0%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
Confidence
AMETEK, Inc. is a global manufacturer of electronic instruments and electromechanical devices, organized into two primary segments: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). The company provides specialized technology solutions for diverse end-markets, including aerospace, defense, medical, and industrial automation. Its portfolio ranges from advanced analytical sensors and power monitoring systems to precision motion control products and specialty metals.
The company operates within the industrial technology sector, a field characterized by high barriers to entry due to the technical complexity and rigorous certification requirements of the products. AMETEK follows a niche-focused business model, often acquiring specialized manufacturers to expand its intellectual property and market share in fragmented industries. This strategy allows the firm to maintain a diversified revenue stream across various economic cycles.
Investors may find it useful to examine ValueRay for further data on this companys valuation metrics.
- Strategic acquisitions drive long-term revenue growth through the disciplined deployment of free cash flow
- Aerospace and defense demand fuels high-margin sales in the Electronic Instruments Group
- Global industrial automation trends accelerate demand for precision motion control and electromechanical devices
- Rising input costs and supply chain volatility impact margins across diverse manufacturing segments
| Net Income: 1.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -1.08 > 1.0 |
| NWC/Revenue: 5.02% < 20% (prev 11.51%; Δ -6.49% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.84b > Net Income 1.53b |
| Net Debt (1.76b) to EBITDA (2.41b): 0.73 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (229.8m) vs 12m ago -0.74% < -2% |
| Gross Margin: 36.56% > 18% (prev 36.18%; Δ 0.38% > 0.5%) |
| Asset Turnover: 48.72% > 50% (prev 46.63%; Δ 2.09% > 0%) |
| Interest Coverage Ratio: 23.90 > 6 (EBIT TTM 1.99b / Interest Expense TTM 83.2m) |
| A: 0.02 (Total Current Assets 3.14b - Total Current Liabilities 2.76b) / Total Assets 16.3b |
| B: 0.77 (Retained Earnings 12.6b / Total Assets 16.3b) |
| C: 0.13 (EBIT TTM 1.99b / Avg Total Assets 15.6b) |
| D: 2.03 (Book Value of Equity 10.9b / Total Liabilities 5.39b) |
| Altman-Z'' = 5.65 = AAA |
| DSRI: 1.06 (Receivables 1.15b/996.5m, Revenue 7.60b/6.94b) |
| GMI: 0.99 (GM 36.18% / 36.56%) |
| AQI: 1.00 (AQ_t 0.74 / AQ_t-1 0.74) |
| SGI: 1.10 (Revenue 7.60b / 6.94b) |
| TATA: -0.02 (NI 1.53b - CFO 1.84b) / TA 16.3b) |
| Beneish M = -2.92 (Cap -4..+1) = A |
As of June 05, 2026, the stock is trading at USD 228.76 with a total of 975,929 shares traded.
Over the past week, the price has changed by +1.47%,
over one month by -0.72%,
over three months by -2.40% and
over the past year by +29.93%.
Ametek has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy AME.
- StrongBuy: 12
- Buy: 2
- Hold: 6
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 259.2 | 13.3% |
P/E Trailing = 34.1163
P/E Forward = 29.5858
P/S = 6.8134
P/B = 4.7407
P/EG = 2.925
Revenue TTM = 7.60b USD
EBIT TTM = 1.99b USD
EBITDA TTM = 2.41b USD
Long Term Debt = 1.06b USD (from longTermDebt, last quarter)
Short Term Debt = 1.11b USD (from shortTermDebt, last quarter)
Debt = 2.24b USD (from shortLongTermDebtTotal, last quarter) + Leases 61.1m
Net Debt = 1.76b USD (calculated: Debt 2.24b - CCE 481.2m)
Enterprise Value = 53.5b USD (51.8b + Debt 2.24b - CCE 481.2m)
Interest Coverage Ratio = 23.90 (Ebit TTM 1.99b / Interest Expense TTM 83.2m)
EV/FCF = 31.43x (Enterprise Value 53.5b / FCF TTM 1.70b)
FCF Yield = 3.18% (FCF TTM 1.70b / Enterprise Value 53.5b)
FCF Margin = 22.42% (FCF TTM 1.70b / Revenue TTM 7.60b)
Net Margin = 20.11% (Net Income TTM 1.53b / Revenue TTM 7.60b)
Gross Margin = 36.56% ((Revenue TTM 7.60b - Cost of Revenue TTM 4.82b) / Revenue TTM)
Gross Margin QoQ = 37.21% (prev 36.93%)
Tobins Q-Ratio = 3.28 (Enterprise Value 53.5b / Total Assets 16.3b)
Interest Expense / Debt = 3.72% (Interest Expense 83.2m / Debt 2.24b)
Taxrate = 17.73% (329.4m / 1.86b)
NOPAT = 1.64b (EBIT 1.99b * (1 - 17.73%))
Current Ratio = 1.14 (Total Current Assets 3.14b / Total Current Liabilities 2.76b)
Debt / Equity = 0.21 (Debt 2.24b / totalStockholderEquity, last quarter 10.9b)
Debt / EBITDA = 0.73 (Net Debt 1.76b / EBITDA 2.41b)
Debt / FCF = 1.03 (Net Debt 1.76b / FCF TTM 1.70b)
Total Stockholder Equity = 10.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.80% (Net Income 1.53b / Total Assets 16.3b)
RoE = 14.39% (Net Income TTM 1.53b / Total Stockholder Equity 10.6b)
RoCE = 17.02% (EBIT 1.99b / Capital Employed (Equity 10.6b + L.T.Debt 1.06b))
RoIC = 11.45% (NOPAT 1.64b / Invested Capital 14.3b)
WACC = 9.07% (E(51.8b)/V(54.0b) * Re(9.33%) + D(2.24b)/V(54.0b) * Rd(3.72%) * (1-Tc(0.18)))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -60.0 | Cagr: -0.38%
[DCF] Terminal Value 72.86% ; FCFF base≈1.71b ; Y1≈1.71b ; Y5≈1.79b
[DCF] Fair Price = 100.6 (EV 24.8b - Net Debt 1.76b = Equity 23.0b / Shares 229.2m; r=9.07% [WACC]; 5y FCF grow -0.62% → 2.50% )
EPS Correlation: 91.25 | EPS CAGR: 5.67% | SUE: 1.72 | # QB: 1
Revenue Correlation: 97.00 | Revenue CAGR: 5.52% | SUE: 0.27 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.99 | Chg30d=+1.07% | Revisions=+54% | Analysts=17
EPS next Quarter (2026-09-30): EPS=2.04 | Chg30d=-0.04% | Revisions=-23% | Analysts=17
EPS current Year (2026-12-31): EPS=8.14 | Chg30d=+0.97% | Revisions=+69% | GrowthEPS=+9.6% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=8.81 | Chg30d=+1.07% | Revisions=+71% | GrowthEPS=+8.3% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: +71%